RSS

cellular therapy

CiMaas, a developer of cellular immunotherapy for cancer, and PharmaCell, a contract manufacturer for cellular therapies and regenerative medicine in Europe, are collaborating in the clinical development of CiMaas’ products. more

News

CTL019, is the first personalised cellular therapy for the treatment of cancer to receive this important classification. more